Risedronate Sodium

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 60723-041
  • Package NDC 60723-041-04
  • Package NDC 60723-041-12
  • Application number ANDA207516
  • SPL ID 460cdef1-681b-7ae4-e063-6294a90a1d55
  • SPL set ID d60a56cb-ef49-4447-9043-7b6879a20d75
  • UNII HU2YAQ274O
  • RxCUI 905024
  • RxCUI 905092
  • RxCUI 905100

What the source publishes

Labeler
Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
Active ingredients
Risedronate Sodium
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:60723-041_460cdef1-681b-7ae4-e063-6294a90a1d55
{
  "name": "Risedronate Sodium",
  "splId": "460cdef1-681b-7ae4-e063-6294a90a1d55",
  "labels": [
    {
      "setId": "d60a56cb-ef49-4447-9043-7b6879a20d75",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d60a56cb-ef49-4447-9043-7b6879a20d75",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d60a56cb-ef49-4447-9043-7b6879a20d75"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BLISTER PACK in 1 CARTON (60723-041-04)  / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)",
      "package_ndc": "60723-041-04",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190401"
    },
    {
      "sample": false,
      "description": "3 BLISTER PACK in 1 CARTON (60723-041-12)  / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)",
      "package_ndc": "60723-041-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190401"
    }
  ],
  "productId": "60723-041_460cdef1-681b-7ae4-e063-6294a90a1d55",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "60723-041",
  "deaSchedule": null,
  "genericName": "Risedronate Sodium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RISEDRONATE SODIUM HEMI-PENTAHYDRATE",
      "strength": "35 mg/1"
    }
  ],
  "applicationNumber": "ANDA207516",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190401",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "HU2YAQ274O"
    ],
    "rxcui": [
      "905024",
      "905092",
      "905100"
    ],
    "spl_set_id": [
      "d60a56cb-ef49-4447-9043-7b6879a20d75"
    ],
    "manufacturer_name": [
      "Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:60723-041_460cdef1-681b-7ae4-e063-6294a90a1d55"